These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 4171806)
21. Effect of phenformin and ethyloestrenol on blood fibrinolytic activity on rabbits maintained on high cholesterol diet. Sharma KK; Chowdhury NK; Sharma AL Indian J Med Res; 1976 Jun; 64(6):915-22. PubMed ID: 977046 [No Abstract] [Full Text] [Related]
22. Pharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival. Hickman JA J Clin Pathol; 1970 Dec; 23(9):797-800. PubMed ID: 5504373 [TBL] [Abstract][Full Text] [Related]
23. Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis. Tengborn L; Hedner U; Nilsson IM J Med; 1982; 13(5-6):353-64. PubMed ID: 6963328 [TBL] [Abstract][Full Text] [Related]
28. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin. Worowski K; Prokopowicz J; Gabryelewicz A Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949 [No Abstract] [Full Text] [Related]
29. Editorial: Fibrinolysis and venous thrombosis. Br Med J; 1974 Nov; 4(5941):365-6. PubMed ID: 4425884 [No Abstract] [Full Text] [Related]
30. [Effects of a combined therapy with ethylestrenol and phenformin on fibrinolysis of selected patients before, during and after surgery]. Brown IK; Santer GJ Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:52-7. PubMed ID: 4505206 [No Abstract] [Full Text] [Related]
32. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade. Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612 [TBL] [Abstract][Full Text] [Related]
33. Behçet's syndrome and oral fibrinolytic therapy. Cunliffe WJ; Roberts BE; Dodman B Br Med J; 1973 May; 2(5864):486-7. PubMed ID: 4712497 [No Abstract] [Full Text] [Related]
34. Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo. Fearnley GR; Chakrabarti R; Evans JF Lancet; 1969 May; 1(7601):910-4. PubMed ID: 4180895 [No Abstract] [Full Text] [Related]
35. [Blood coagulation and fibrinolytic system in patients with marked coronary arteriosclerosis]. Gritsiuk AI; Sopina NV Kardiologiia; 1970 Oct; 10(10):9-16. PubMed ID: 4251295 [No Abstract] [Full Text] [Related]
36. Phenformin and stanozolol in blood fibrinolytic activity. Menon IS; Cunliffe WJ; Weightman D; Dewar HA Br Med J; 1970 Feb; 1(5693):428. PubMed ID: 4244848 [No Abstract] [Full Text] [Related]
37. Phenformin and ethyloestrenol in recurrent venous thrombosis. Nilsson IM; Hedner U; Isacson S Acta Med Scand; 1975; 198(1-2):107-13. PubMed ID: 1166815 [TBL] [Abstract][Full Text] [Related]
38. Treatment of Behcet's syndrome with phenformin and ethyloestrenol. Cunliffe WJ; Menon IS Lancet; 1969 Jun; 1(7608):1239-40. PubMed ID: 4182415 [No Abstract] [Full Text] [Related]
39. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis. Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894 [TBL] [Abstract][Full Text] [Related]